Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • HATU: High-Efficiency Peptide Coupling Reagent for Amide ...

    2026-01-19

    HATU: High-Efficiency Peptide Coupling Reagent for Amide Bond Formation

    Executive Summary: HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) is a gold-standard reagent for peptide coupling, enabling rapid formation of amide bonds with high yield and selectivity (Vourloumis et al., 2022). Its mechanism operates via activation of carboxylic acids to form OAt-active esters, facilitating efficient nucleophilic attack by amines or alcohols. HATU is typically used with DIPEA in DMF and is insoluble in water or ethanol but dissolves in DMSO at ≥16 mg/mL. APExBIO's HATU (A7022) is widely adopted in pharmaceutical and biochemical research due to its reproducibility and compatibility with complex synthetic workflows [product page]. Solutions should be freshly prepared and stored at -20°C desiccated for optimal stability.

    Biological Rationale

    Peptide synthesis underpins the development of enzyme inhibitors, therapeutic peptides, and molecular probes. M1 zinc aminopeptidases, such as ERAP1, ERAP2, and IRAP, are key drug targets in immunology and neurobiology (Vourloumis et al., 2022). High-fidelity amide bond formation is essential for assembling peptide-based inhibitors with defined stereochemistry and activity. Carboxylic acid activation is a bottleneck in peptide chemistry, necessitating efficient coupling reagents. HATU addresses this by providing high yields, low racemization rates, and compatibility with protected amino acids and derivatives. The use of HATU has enabled the synthesis of nanomolar inhibitors with strict diastereo- and regio-selectivity for targets such as IRAP [DOI]. Its performance is particularly notable when regio- and stereoselectivity are critical, outperforming traditional coupling systems [see further discussion].

    Mechanism of Action of HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate)

    HATU activates carboxylic acids to form OAt-active esters, enhancing their electrophilicity. The mechanism involves initial formation of a reactive intermediate between the carboxylic acid and HATU, typically in the presence of DIPEA (N,N-diisopropylethylamine) in DMF. The OAt-active ester intermediate is then rapidly attacked by the nucleophilic amine, yielding the desired amide bond with high chemoselectivity. This process minimizes side reactions, such as epimerization and hydrolysis, particularly compared with carbodiimide-based reagents. HATU is structurally characterized by a triazolopyridinium core and a hexafluorophosphate counterion, conferring enhanced solubility in polar aprotic solvents and improved stability. The mechanism and structural specifics are detailed in recent mechanistic studies [mechanistic depth], clarifying and extending prior work on carbodiimide alternatives.

    Evidence & Benchmarks

    • HATU enables high-yield peptide coupling (typically >95%) under standard conditions (DMF, DIPEA, room temperature, 1–2 h) (Vourloumis et al., 2022).
    • Formation of OAt-active esters by HATU reduces racemization rates to <2% in model dipeptide couplings compared to >5% for carbodiimide reagents [Table S2].
    • HATU is effective for coupling sterically hindered amino acids, such as α-hydroxy-β-amino acid derivatives used in bestatin analog synthesis [Scheme 1].
    • Insoluble in water and ethanol, HATU dissolves at ≥16 mg/mL in DMSO, facilitating high-concentration reactions [APExBIO].
    • HATU enables regio- and stereoselective assembly of nanomolar inhibitors for M1 aminopeptidases, outperforming other coupling reagents in selectivity and efficiency [Results section].

    Applications, Limits & Misconceptions

    HATU is primarily employed in:

    • Solid-phase peptide synthesis (SPPS) protocols for therapeutic and research peptides.
    • Solution-phase amide bond formation in complex organic synthesis workflows.
    • Esterification reactions for protected carboxylic acids or peptide side chains.
    • Preparation of peptide-based enzyme inhibitors and small-molecule drug candidates.

    Contrary to some misconceptions, HATU is not universally superior for all carboxylic acid activations. It is less effective in highly aqueous systems or with unprotected, highly nucleophilic side chains that may compete in the coupling step. For more nuanced mechanistic strategies and troubleshooting, see "HATU: Optimizing Peptide Coupling Chemistry for Advanced ..."—this article updates protocol details and expands on selectivity considerations beyond those guides.

    Common Pitfalls or Misconceptions

    • HATU is insoluble in water and ethanol; attempting aqueous couplings leads to poor efficiency (APExBIO).
    • Pre-activated HATU solutions rapidly hydrolyze; solutions must be freshly prepared—long-term storage is not recommended (APExBIO).
    • Racemization is minimized but not eliminated: reactions with highly base-sensitive amino acids may still require additional precautions (Vourloumis et al., 2022).
    • HATU is not well-suited for activating carboxylic acids with highly hindered ortho substituents—alternative reagents may be preferred.
    • HATU is not compatible with all nucleophiles; primary amines and alcohols are optimal, while bulky or electron-poor nucleophiles react sluggishly.

    Workflow Integration & Parameters

    For optimal results with HATU:

    • Use freshly prepared HATU in dry DMF or DMSO at typical concentrations of 0.05–0.2 M; avoid water or ethanol as solvents.
    • Add HATU to the carboxylic acid and base (e.g., DIPEA) prior to nucleophile addition to minimize side reactions.
    • Maintain inert atmosphere (e.g., N2 or Ar) for sensitive substrates.
    • For solid-phase peptide synthesis, use HATU in 1.2–2.0 equivalents relative to amino acid, with DIPEA in 2–4 equivalents.
    • Monitor reaction progress by HPLC or LC-MS for high-value syntheses.
    • Store HATU desiccated at -20°C; the A7022 kit from APExBIO is provided in stable, sealed containers (APExBIO).

    This article clarifies and extends the mechanistic focus in "HATU in Peptide Synthesis: Mechanistic Depth and Next-Gen..." by providing explicit troubleshooting steps and workflow benchmarks. For a broader overview of amide bond formation strategies, see "HATU: High-Efficiency Peptide Coupling Reagent for Amide ..."—this article updates best practice parameters for modern labs.

    Conclusion & Outlook

    HATU remains the peptide coupling reagent of choice for high-efficiency, low-racemization amide bond formation in complex organic synthesis. Its mechanism—via OAt-active ester intermediates—enables robust, reproducible coupling of even challenging amino acid derivatives, facilitating the synthesis of advanced inhibitors and therapeutic peptides. APExBIO's HATU (A7022) is validated for pharmaceutical and biochemical workflows, with clear guidance on storage and use conditions. Ongoing research into new coupling strategies continues, but HATU's advantages in selectivity and reliability are well established (Vourloumis et al., 2022). For up-to-date synthesis protocols and troubleshooting, practitioners should reference both peer-reviewed literature and product-specific documentation.